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ABSTRACT: Highly substituted coumarins, privileged and
versatile scaffolds for bioactive natural products and fluorescence
imaging, are obtained via a Pd(II)-catalyzed direct C−H
alkenylation reaction (Fujiwara−Moritani reaction), which has
emerged as a powerful tool for the construction and functionaliza-
tion of heterocyclic compounds because of its chemical versatility
and its environmental advantages. Thus, a selective 6-endo
cyclization led to 4-substituted coumarins in moderate yields. Selected examples have been further functionalized in C3 through
a second intermolecular C−H alkenylation reaction to give coumarin-acrylate hybrids, whose fluorescence spectra have been
measured.
■ INTRODUCTION
Coumarins (2H-chromen-2-nes or benzo-α-pyrones) are
privileged scaffolds of a large variety of natural products1,2
(e.g., pestalasins A-E3,4 and lamellarins5,6) and/or synthetic
molecules, as exemplified by the antioxidant umbelliferone,7
choleretic and antispasmodic hymecromone (4-methylumbel-
liferone),8 anti-inflammatory toddaculin,9 or anti-HIV agent 4-
propylcoumarins10 (Figure 1). Owing to their outstanding
optical properties, these coumarin fluorophores have found
applications as fluorescent probes and tracers in biology, laser
dyes, solar energy collectors, etc.11−13 Additionally, coumarins
are widely used as additives in food and cosmetics,14,15 as well
as agrochemicals,16 and pharmaceuticals.17 In particular, 4-
arylcoumarins, a subgroup of flavonoids, have received great
attention because they exhibit important biological activities,
such as anti-HIV,18 antibacterial,19 antiprotozoal,20 and
cytotoxic properties.21 For example, 5,7,4′-trimethoxy and
5,7-dimethoxy-4-phenylcoumarins have been tested for their
anti-inflammatory activity, specifically as COX inhibitors,
which opens the door to future developments as these
enzymes are also associated with cancer and neuropsychiatric
diseases such as schizophrenia.22 The introduction of a fused
heterocyclic moiety into the coumarin core usually leads to
compounds with promising or even unprecedented proper-
ties.23 For example, furo[3,2-g]coumarins (e.g., psoralen,
xanthoxin, or bergapten) are used in treatment of several
skin disorders (psoriasis and vitiligo).24 Therefore, the
development of synthetic methods to construct and function-
alize the coumarin core has attracted much attention over the
past decades. Classical approaches for the preparation of
coumarin derivatives usually involve the acid- or base-catalyzed
condensation reactions of phenol derivatives with esters of
acrylic acids (the Pechmann reaction) or with carbonyl
compounds (Perkin, Wittig reaction, or Knoevenagel-type
reactions).25−27 Some milder methods that do not use phenol
precursors have also been developed, such as the PIDA/I2-
mediated reactions of substituted phenyl acrylic acids28 and
visible-light induced synthesis of functionalized coumarins.29
Transition-metal-catalyzed, particularly palladium−cata-
lyzed, inter- or intramolecular heteroannulation reactions30,31
represent an excellent alternative for the construction of the
coumarin framework.32 Representative examples include the
intramolecular Mizoroki−Heck reaction of o-halophenyl 3-
alkenoates,33 the tandem intermolecular Heck/cyclization
between aryl halides and acrylates,34−36 or the Suzuki cross-
coupling/cyclization of 2-(pinacolboronate)phenol and β-
brominated dehydroaminoacids.37 In addition, palladium-
catalyzed intermolecular carbonylative cyclization of o-
halophenols with alkynes38,39 or salicylic aldehydes with benzyl
chlorides40 has been reported. More recently, Gilmour et al.41
has reported a Pd(0)-catalyzed cascade annulation of 2-
halophenols with β-borylacrylates as ambiphilic C3-synthons
to generate C3 and C4-substituted coumarins. However, the
transition-metal-catalyzed oxidative coupling reactions42 are
even more attractive strategies for the synthesis of heterocyclic
scaffolds as coumarins, as they avoid the use of preactivated
coupling partners (halides, triflates, boronates, etc.). In this
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context, the oxidative cyclocarbonylation43 or carboxylation44
of 2-vinylphenols are efficient procedures for the synthesis of 4-
substituted coumarins. The inter- or intramolecular hydro-
arylation of alkynes provides a direct and simple route to these
heterocycles from phenols and propiolates or aryl propiolates,
respectively.45 The formation of coumarins by addition of
phenols and alkynoates via palladium(II)-catalyzed C−H
insertion is an excellent example to illustrate the potential of
this methodology.46 The palladium(II)-catalyzed intermolecu-
lar C−H alkenylation reaction of phenols and acrylates
followed by intramolecular C−O formation, first reported by
Kitamara et al.47 in 2005 and later developed by Maiti et al.48
and Shi et al,49 has given good results mainly for the synthesis
of coumarins with no substituents at the pyrane ring. A related
tandem dehydrogenation/oxidative Heck reaction starting
from 4-phenylcyclohexanone to generate the intermediate
phenol has also been reported.50 Therefore, we decided to
investigate the intramolecular C−H alkenylation variant51,52 of
aryl alkenoates and cinnamates to prepare 4-alkyl and 4-aryl-
substituted coumarins with alkoxy groups at the aromatic ring,
a structural feature common to biologically active coumarins
(Scheme 1). The strategy involves a 6-endo-trig cyclization,
which could be accomplished by controlling the positional
selectivity of C−H activation, as we have previously
demonstrated in the Pd(II)-catalyzed intramolecular 6-endo
C−H alkenylation of N-arylacrylamides53 and N-substituted N-
allylanilines54 for the construction of quinolone and
dihydroquinoline cores, respectively. The effect of the
substitution patterns of the benzene ring and the alkene on
the reactivity and regioselectivity would be investigated. In
addition, as conjugation of coumarin nucleus with an
unsaturated moiety at the C-3 position can play a pivotal
role in the anticancer activity of these heterocycles,55 we
decided to carry out an intermolecular alkenylation reaction on
the coumarin ring with α,β-unsaturated esters to generate new
coumarin-acrylate hybrids.
■ RESULTS AND DISCUSSION
We started the study of the reaction conditions (palladium
catalyst and oxidant) using cinnamate 1a as the model
substrate (Table 1). We selected the reaction conditions that
had been previously employed for the 6-endo cyclization of N-
aryl acrylamides to quinolones53 as a starting point, carrying
out the reactions at room temperature in acetic acid and in the
presence of p-TsOH (1 equiv) as an additive. The presence of
this acid has been shown to be a determinant to increase the
reactivity in this type of reaction.53,54,56,57 However, when
palladium acetate was used as the catalyst using copper acetate
or p-benzoquinone as oxidants, no conversion at all was
observed after 30 h at rt, recovering unreacted 1a (Table 1,
entries 1 and 2). The use of t-butyl perbenzoate in
combination with copper acetate as an oxidant was required
Figure 1. Selected bioactive compounds with the coumarin core.
Scheme 1. Synthesis of Coumarins via C−H Alkenylation
Table 1. Optimization of 6-Endo Cyclization of 1a
entry [Pd] [O] L t (h) 2a (%)
1 Pd(OAc)2
a Cu(OAc)2
b - 30 -c
2 Pd(OAc)2
a p-BQb - 30 -c
3 Pd(OAc)2
a PhCO3tBu
d - 24 9
4 Pd(dba)2
a PhCO3tBu
d - 24 5
5 PdCl2(CH3CN)2
a PhCO3tBu
d - 8 10e
6 PdCl2(CH3CN)2
a PhCO3tBu
d - 24 -f
7 PdCl2(CH3CN)2
a PhCO3tBu
d - 4g -f
8 PdCl2(CH3CN)2
a PhCO3tBu
d L1a 24 23
9 PdCl2(CH3CN)2
h PhCO3tBu
d - 24 25
10 PdCl2(CH3CN)2
a PhCO3tBu
d - 24i 25
11 PdCl2(CH3CN)2
a F+d,j - 24 74
a5 mol %. b1 equiv. cStarting material was recovered. dCu(OAc)2 (5
mol %) was used as a co-oxidant. eConversion: 31%. fDecomposition.
gThe reaction was carried out under reflux. h10 mol %. i2% wt. PT
aqueous solution was used as solvent instead of HOAc. jN-Fluoro-
2,4,6-trimethylpyridinium triflate (1.2 equiv) was used as the oxidant
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to obtain some reactivity, although low yields of the
corresponding coumarin 2a were isolated, observing also the
formation of decomposition products (Table 1, entries 3 and
4). A change in the palladium catalyst to bis(acetonitrile)-
dichloropalladium(II) resulted in a low conversion of the
substrate (69% of 1a was recovered) after 8 h, but with a low
isolated yield of 2a (Table 1, entry 5). A longer reaction time
or higher reaction temperature was detrimental due to
decomposition of the substrate (Table 1, entries 6 and 7).
The use of a pyridine ligand (L1), a higher catalyst loading (10
mol %), or the use of an aqueous medium for the reaction
resulted in increased but still low isolated yields (Table 1,
entries 8−10). In no case, open-ring or decarboxylated
products could be observed in isolable quantities. It was
necessary to use a stronger oxidant such as N-fluoro-2,4,6-
trimethylpyridinium triflate (F+) to obtain a complete
conversion after 24 h, affording coumarin 2a in good isolated
yield (Table 1, entry 11). This oxidant has been successfully
employed in related intermolecular C−H alkenylation
reactions in which the use of weaker oxidants gave low
reactivity.58−60 It is noteworthy that the reaction was
completely regioselective toward the formation of the 6-endo
cyclization product (coumarin 2a), not observing the
formation of the corresponding 5-exo cyclization product,
benzofuran-2(3H)-one. Finally, a control experiment was
carried out and in the absence of palladium, the reaction did
not take place and unreacted 1a was recovered after 24 h at rt.
These reaction conditions were applied to a series of
cinnamates and enoates 1b−1k. The results are summarized in
Table 2.
As shown, the results obtained were highly dependent on the
substrate employed. Different substitution patterns on the
aromatic ring at C4 are tolerated, and coumarins 2b−d were
obtained in good isolated yields (Table 2). Nevertheless, the
obtention of 2e required the use of a higher catalyst loading
(10 mol %). A heteroaromatic ring, such as furan, could also be
introduced at C4, although in a lower yield (2f, 21%). When
an electron-deficient aryl group was introduced, 2g was
obtained in a much lower yield (28%). Interestingly, when
the reaction temperature was increased to 70 °C, the
regioselectivity of the reaction was lost, isolating both the 6-
endo and 5-exo cyclization products (2g and 3g, respectively)
in low yields, together with decomposition products. Under
these reaction conditions, unsubstituted or 4-alkyl substituted
coumarins 2h−k were obtained only in moderate to low yields
(Table 2), though no starting material could be recovered. An
increase of the reaction temperature to 70 °C did not improve
the results. It was also shown that the reaction conditions are
not compatible with the presence of acyl groups on the alkene
(1l R1 = CO2Et; 1m R
1 = COAr) or with the substitution on
the α-position of the alkene (1n and 1o R = Ph and CH3,
respectively). In these cases, complex mixtures of products
were obtained, not isolating coumarins 2l−2o. These results
show that it is possible to access the coumarin framework via
6-endo cyclization, but this procedure is not as efficient as it
was shown for the synthesis of quinolones from the
corresponding amides.53 This difference in reactivity could
be attributed to the instability of the esters in acidic media,
leading to decomposition when long reaction times are
required. Consequently, the reaction conditions were re-
evaluated to use an alternative solvent to acetic acid, using in
this case pent-5-enoate 1j as the model substrate (Table 3).
The change of acetic acid for a non-protic solvent, such as
dichloromethane, led to a low conversion at room temperature
(Table 3, entry 1). The use of an apolar solvent, such as
mesitylene, in combination with a smaller proportion of acetic
acid61 led to an increase of the isolated yield of 2j, although in
a longer reaction time (Table 3, entry 2). The reactivity could
be recovered at 40 °C, with slight erosion of the yield (Table 3,
entry 3). When the reaction was carried out in mesitylene, the
presence of p-TsOH was essential, as no reactivity was
observed even after 96 h at rt in its absence (Table 3, entry 4).
Finally, a moderate yield of 2j could be obtained at 70 °C
(Table 3, entry 5). The use of these reaction conditions
(mesitylene, 70 °C) resulted in a significant increase in the
Table 2. Synthesis of 4-Substituted Coumarins 2a−g
aYield (%) of the pure isolated compound (rt, 6−24 h). b10 mol % of
the catalyst was used; 79% conversion. c75% conversion. dYield (%)
of the pure isolated compound (70 °C, 24 h). eDecomposition.
ACS Omega http://pubs.acs.org/journal/acsodf Article
https://doi.org/10.1021/acsomega.1c03469
ACS Omega 2021, 6, 29483−29494
29485
yield of coumarin 2h (69% vs 20%) and 4-alkyl substituted
coumarins 2i−2k (Table 4). The yield of 4-aryl substituted
coumarin 2g could not be improved under these conditions,
although in this case, the formation of the 5-exo product 3g
was not observed by NMR. Finally, the extension to different
substitution patterns in the aromatic ring was also studied
(Table 4). It was clear that an electron-rich aromatic ring is a
determinant to obtain reactivity under these conditions.
Two mechanistic pathways could be proposed for this type
of oxidative alkenylation reaction. On one hand, arene
metalation with an electrophilic Pd(II) species would give an
aryl-Pd(II) species I, followed by syn-migratory insertion onto
the alkene to give II, and syn elimination, after isomerization to
III, to afford coumarin 2.53 Alternatively, the alkene could be
first activated by the palladium catalyst (IV), followed by anti-
addition of the aromatic ring to give also III, and syn
elimination would lead to 2 (Scheme 2). In both cases, an
electron-rich aromatic ring would be more reactive. As shown
on Table 4, 6,7-dialkoxycoumarins 2p, 2q, and 2s could be
obtained regioselectively, although in lower yields, as the 5,6,7-
trimethoxy-substituted coumarin 2r, but no unreacted
substrate was recovered. Although other aromatic substitution
patterns were tested, no reactivity was observed with 3,5-
dimethylphenyl, 3-methoxyphenyl, and 3-methoxy-5-methyl
cinnamates, while complex mixtures of products were formed
when using the corresponding (E)-but-2-enoates (see the
Supporting Information for the substrates tested, 1t−1y).
The selective functionalization of the coumarin skeleton is
also an important issue as, in addition to the biological
properties, the extension of the conjugation could affect, for
instance, their photophysical properties.62,63 Thus, several
procedures have been developed for the C3 alkenylation of
coumarins. For instance, palladium-catalyzed decarboxylative
couplings have been described for the functionalization of
coumarins with cinnamic acids64 and for the reaction of
coumarin-3-carboxylic acid with acrylates.65 In addition, the
selective C3 alkenylation of non-substituted coumarins has also
been efficiently accomplished through the oxidative Heck
reaction.66 Thus, we decided to study the derivatization of
selected 4-substituted coumarins through a second intermo-
lecular C−H alkenylation reaction.
First, we tested the conditions used for the 6-endo-
cyclization, but no intermolecular alkenylation reaction with
t-butyl acrylate was observed. After some experimentation, we
found that the best results were obtained using the reaction
conditions previously developed for the alkenylation of
quinolones.53 However, in most cases, conversions were low
and 30−40% of the starting material was recovered (Table 5).
When longer reaction times or higher temperatures were used,
complex mixtures of products were isolated. We tried to
optimize the reaction conditions by changing the oxidant or
the palladium source, but the results could not be improved
(see the Supporting Information). As shown in Table 5, C4
aryl- and methyl-substituted coumarins 2a,d,e,i could be
alkenylated with methyl or t-butyl acrylate using palladium
acetate in the presence of silver acetate and pivalic acid
obtaining alkenylated coumarins 4a−f in moderate yields
(Table 5, entries 1−6). Substitution on the β-position of the
alkene is also possible, obtaining 4g in moderate yield (Table
5, entry 7).
As 3-vinyl and 3-styryl coumarins62,63 can be interesting
fluorophores, the absorption and emission properties of
selected coumarins 2a,d,e and 4a−d were also studied (see
Table 6, Figure 2, and the Supporting Information). All
coumarins showed UV−vis absorption, only one absorption
band around λmax. = 375 nm for 4-aryl coumarins 2a,d,e and
around λabs. = 300 nm for their C3 alkenylated derivatives 4a−
d. This shift to a lower wavelength upon introduction of the
acrylate moiety reflects the loss of coplanarity of the aromatic
ring and the coumarin nucleus, thus decreasing delocalization.
C3 alkenylation in the coumarin core leads to considerable
changes in the fluorescence properties of coumarins 4a−d,
whose maximum emission were more blue-shifted than those
of coumarins 2 (λem. = 452−480 nm vs λem. = 435−446 nm)
and presented higher Stoke shifts (up to 180) (Table 6).
Table 3. Cyclization Reaction Conditions for 1j
entry solvent T (°C) t (h) 2j (%)
1a CH2Cl2 rt 24 8
b
2c mesitylene/HOAc 4:1 rt 96 37
3c mesitylene/HOAc 4:1 40 24 33
4c mesitylene rt 96 -d
5c mesitylene 70 24 49
a5 mol% of catalyst. bConversion: 17%. c10 mol% of catalyst. dNo p-
TsOH was added; no reaction.
Table 4. Synthesis of 4-Substituted Coumarins in
Mesitylene
aYield (%) of the pure isolated compound. b5 mol% of catalyst.
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Fluorescent organic dyes with large Stoke shift are essential for
biological applications.67−69
In conclusion, it has been shown that 4-aryl-substituted
coumarins can be obtained in moderate to good yields via
palladium(II)-catalyzed C−H alkenylation reactions. 4-Aryl-
substituted derivatives can be obtained in acetic acid at room
temperature, while mesitylene at 70 °C is required to obtain
moderate yields of 4-alkyl-substituted coumarins, avoiding
decomposition in an acidic medium. However, the procedure
is limited to an electron-rich aromatic ring for the cyclization
to proceed efficiently. The coumarin skeleton can be further
functionalized via C3 intermolecular alkenylation. Additionally,
the fluorescence spectra of selected coumarins have been
measured to provide perspective for potential applications.
■ EXPERIMENTAL SECTION
General Experimental Methods. Melting points were
measured in unsealed capillary tubes. The NMR spectra were
obtained at 300 MHz for 1H and 75.5 MHz for 13C or at 500
MHz for 1H and 125.7 MHz for 13C using CDCl3 as solvent
and internal standard at 20−25 °C. Distortionless enhance-
ment by polarization transfer (DEPT) experiments and 2D
correlation experiments (COSY, heteronuclear single-quantum
coherence (HSQCed), or heteronuclear multiple bond
correlation (HMBC)) were used when necessary for the
assignments of individual 13C and 1H resonances. Electron
impact (EI, 70 eV), chemical ionization (CI, 230 eV), or
electrospray ionization (ESI+) sources were used for obtaining
the mass spectra. A TOF detector was employed for the
obtention of exact mass. The IR spectra were obtained using
an ATR instrument. The fluorescence spectra were measured
using a Jasco FP-6500 spectrofluorimeter using acetonitrile as
solvent at 2.3 mM. The emission spectra were acquired by
irradiating the sample at its maximum absorbance. Both
excitation and emission spectra were collected with a 3 nm slit
bandwidth and were recorded at 25 °C. TLC was carried out
with 0.2 mm-thick silica gel plates. Visualization was
accomplished by UV light. Flash column chromatography
was carried out on silica gel (230−400 mesh). All solvents used
in reactions were purified according to standard procedures.
Palladium catalysts were purchased from Aldrich and were
used without further purification: Pd(OAc)2, 98% purity, and
PdCl2(CH3CN)2, 99% purity.
Intramolecular Alkenylation of Enoates 1 and Syn-
thesis of Coumarins 2: General Procedure. 1-Fluoro-
2,4,6-trimethylpyridinium trifluoromethanesulfonate (1.2
mmol), Cu(OAc)2 (0.05 mmol), p-TsOH (1 mmol), and
Scheme 2. Mechanistic Pproposals for the 6-Endo Cyclization: Arene Metalation vs Alkene Activation
Table 5. Intermolecular C−H Alkenylation of Coumarins 2
entry 2 R1 R2 R3 4 yield (%)a
1 2a Ph CH3 H 4a 31
2 2a Ph t-Bu H 4b 31
3 2d 4(tBu)C6H4 CH3 H 4c 52
4 2e 3,4(OMe)C6H4 CH3 H 4d 28
5 2i CH3 CH3 H 4e 45
6 2i CH3 t-Bu H 4f 53
7 2i CH3 CH3 CH3 4 g 44
aYield (%) of the pure isolated compound; in all cases, 30−40% of
the unreacted starting material was also recovered.
Table 6. Absorption and Emission Maxima of Selected
Coumarins 2 and 4
entry compd λabs
a (nm) λem
b (nm) ΔStokec (nm)
1 2a 375 435 60
2 2d 377 441 64
3 2e 376 446 70
4 4a 301 453 152
5 4b 302 452 150
6 4c 300 480 180
7 4d 300 455 155
aThe maximum absorption wavelength in acetonitrile (2.3 mM).
bExcited at the maximum absorption wavelength in acetonitrile (2.3
mM). cStoke shift = λem − λabs.
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PdCl2(CH3CN)2 (0.05 or 0.1 mmol) were added sequentially
over a solution of the corresponding enoate 1 (1 mmol) in
HOAc or mesitylene (4 mL). The mixture was stirred at room
temperature or at 70 °C for 4−24 h. The solvent was removed
under vacuum and the residue was dissolved in EtOAc (5 mL).
The solution was washed with a 2 M aqueous solution of
Na2CO3 (2 × 15 mL) and brine (2 × 15 mL). The aqueous
phase was re-extracted with EtOAc (10 mL) and the combined
organic extracts were dried (Na2SO4) and concentrated in
vacuo. Flash column chromatography (silica gel, hexane/
EtOAc) afforded coumarins 2.
5,7-Dimethoxy-4-phenyl-2H-chromen-2-one (2a). Cou-
marin 2a was prepared from 1a (101.7 mg, 0.36 mmol), 1-
fluoro-2,4,6-trimethylpyridinium trifluoromethanesulfonate
(130.7 mg, 0.43 mmol), Cu(OAc)2 (3.3 mg, 0.018 mmol),
p-TsOH (69.1 mg, 0.36 mmol), and PdCl2(CH3CN)2 (4.7 mg,
0.018 mmol) in HOAc (1.4 mL). The mixture was stirred at
room temperature for 24 h, and after the work-up, flash
column chromatography (silica gel, hexane/EtOAc 8/2)
afforded 2a (75 mg, 74%) as a solid, whose data are
coincidental with those reported:46 mp (CH2Cl2): 164−166
°C [lit.46 mp (CH2Cl2/hexanes) 164−165 °C]; IR (ATR)
1713 cm−1 (CO); 1H NMR (CDCl3, 300 MHz): δ 3.42 (s,
3H, OCH3), 3.87 (s, 3H, OCH3), 6.01 (s, 1H, H3), 6.23 (d, J =
2.3 Hz, 1H, H6), 6.53 (d, J = 2.3 Hz, 1H, H8), 7.22−7.30 (m,
2H, H3′, H5′), 7.32−7.41 (m, 3H, H2′, H4′, H6′); 13C{1H}
NMR (CDCl3, 75.5 MHz): δ 55.4 (OCH3), 55.8 (OCH3),
93.6 (C8), 95.8 (C6), 103.6 (C4a), 112.7 (C3), 127.1 (C2′, C6′),
127.3 (C3′, C5′), 127.9 (C4′), 139.8 (C1′), 155.7 (C4), 157.2
(C8a), 158.2, 163.4 (C5, C7), 160.9 (CO); MS (CI) m/z (rel
intensity) 284 (MH+ + 1, 18), 283 (MH+, 100), 282 (34), 254




(2b). Coumarin 2b was prepared from 1b (117.6 mg, 0.37
mmol), 1-fluoro-2,4,6-trimethylpyridinium trifluoromethane-
sulfonate (131.2 mg, 0.45 mmol), Cu(OAc)2 (3.5 mg, 0.019
mmol), p-TsOH (72.2 mg, 0.37 mmol), and PdCl2(CH3CN)2
(4.9 mg, 0.019 mmol) in HOAc (1.5 mL). The mixture was
stirred at room temperature for 6 h, and after the work-up,
flash column chromatography (silica gel, hexane/EtOAc 7/3)
afforded 2b (85.5 mg, 73%) as a solid, whose data are
coincidental with those reported:70 mp (CH2Cl2): 153−155
°C [lit.70 mp (methanol) 151−152 °C]; IR (ATR) 1716 cm−1
(CO); 1H NMR (CDCl3, 300 MHz): δ 3.46 (s, 3H,
OCH3), 3.84 (s, 6H, 2 × OCH3), 5.95 (s, 1H, H3), 6.22 (d, J =
2.4 Hz, 1H, H6), 6.48 (d, J = 2.4 Hz, 1H, H8), 6.88 (d, J = 8.8
Hz, 2H, H3′, H5′), 7.19 (d, J = 8.8 Hz, 2H, H2′, H6′);
13C{1H}
NMR (CDCl3, 75.5 MHz): δ 55.3 (OCH3), 55.4 (OCH3),
55.7 (OCH3), 93.6 (C8), 95.7 (C6), 103.6 (C4a), 112.5 (C3),
112.7 (C3′, C5′), 128.7 (C2′, C6′), 132.0 (C1′), 155.5 (C4),
157.2 (C8a), 158.3 (C4′), 159.6, 163.3 (C5, C7), 160.9 (CO);
MS (CI) m/z (rel intensity) 314 (MH+ + 1, 20), 313 (MH+,
100), 312 (60), 284 (18); HRMS (CI) Calcd. for C18H17O5
[MH+]: 313.1071; found, 313.1061.
5,7-Dimethoxy-4-(p-tolyl)-2H-chromen-2-one (2c). Cou-
marin 2c was prepared from 1c (105.9 mg, 0.36 mmol), 1-
fluoro-2,4,6-trimethylpyridinium trifluoromethanesulfonate
(123.2 mg, 0.43 mmol), Cu(OAc)2 (3.2 mg, 0.018 mmol),
p-TsOH (67.5 mg, 0.36 mmol), and PdCl2(CH3CN)2 (4.6 mg,
0.018 mmol) in HOAc (1.4 mL). The mixture was stirred at
room temperature for 24 h, and after the work-up, flash
column chromatography (silica gel, petroleum ether/EtOAc t
8/2) afforded 2c (75.9 mg, 72%) as a solid, whose data are
coincidental with those reported:70 mp (CH2Cl2): 131−133
°C [lit.70 mp (ethanol/water) 131−133 °C]; IR (ATR) 1712
cm−1 (CO); 1H NMR (CDCl3, 300 MHz): δ 2.42 (s, 3H,
CH3), 3.47 (s, 3H, OCH3), 3.88 (s, 3H, OCH3), 6.00 (s, 1H,
H3), 6.25 (d, J = 2.4 Hz, 1H, H6), 6.53 (d, J = 2.4 Hz, 1H, H8),
7.15−7.21 (m, 4H, H2′, H3′, H5′, H6′); 13C{1H} NMR (CDCl3,
75.5 MHz): δ 21.3 (CH3), 55.4 (OCH3), 55.8 (OCH3), 93.6
(C8), 95.8 (C6), 103.6 (C4a), 112.7 (C3), 127.2 (C2′, C6′),
128.0 (C3′, C5′), 136.9 (C4′), 137.8 (C1′), 155.8 (C4), 157.2
(C8a), 158.3, 161.0 (C5, C7), 163.3 (CO); MS (ESI
+) m/z (rel
intensity) (MH+ + 1, 15), 297 (MH+, 100); HRMS (ESI+)
Calcd. for C18H17O4 [MH
+]: 297.1127; found, 297.1132.
4-[4-(tert-Butyl)phenyl]-5,7-dimethoxy-2H-chromen-2-
one (2d). Coumarin 2d was prepared from 1d (122.0 mg, 0.36
mmol), 1-fluoro-2,4,6-trimethylpyridinium trifluoromethane-
sulfonate (124.4 mg, 0.43 mmol), Cu(OAc)2 (3.3 mg, 0.018
mmol), p-TsOH (68.2 mg, 0.36 mmol), and PdCl2(CH3CN)2
(4.7 mg, 0.018 mmol) in HOAc (1.4 mL). The mixture was
stirred at room temperature for 24 h, and after the work-up,
flash column chromatography (silica gel, petroleum ether/
EtOAc 8/2) afforded 2d (101.0 mg, 83%) as a solid: mp
(CH2Cl2): 176−178 °C; IR (ATR) 1718 cm−1 (CO); 1H
NMR (CDCl3, 300 MHz): δ 1.38 (s, 9H, C(CH3)3), 3.43 (s,
3H, OCH3), 3.87 (s, 3H, OCH3), 6.02 (s, 1H, H3), 6.25 (d, J =
2.4 Hz, 1H, H6), 6.53 (d, J = 2.4 Hz, 1H, H8), 7.19−7.22 (m,
2H, H3′, H5′), 7.39−7.42 (m, 2H, H2′, H6′); 13C{1H} NMR
(CDCl3, 75.5 MHz): δ 31.3 (C(CH3)3), 34.7 (C(CH3)3), 55.5
(OCH3), 55.8 (OCH3), 93.6 (C8), 95.8 (C6), 103.7 (C4a),
Figure 2. Excitation and emission spectra of coumarins 4a−d at 2.3 mM in acetonitrile.
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112.5 (C3), 124.2 (C2′, C6′), 127.0 (C3′, C5′), 136.8 (C4′),
151.1 (C1′), 155.8 (C4), 157.2 (C8a), 158.3, 161.0 (C5, C7),
163.3 (CO); MS (ESI+) m/z (rel intensity) 340 (MH+ + 1,
17), 339 (MH+, 100); HRMS (ESI+) Calcd. for C21H23O4
[MH+]: 339.1596; found, 339.1600.
4-(3,5-Dimethoxyphenyl)-5,7-dimethoxy-2H-chromen-2-
one (2e). Coumarin 2e was prepared from 1e (115.6 mg, 0.34
mmol), 1-fluoro-2,4,6-trimethylpyridinium trifluoromethane-
sulfonate (116.5 mg, 0.40 mmol), Cu(OAc)2 (3.0 mg, 0.017
mmol), p-TsOH (63.9 mg, 0.34 mmol), and PdCl2(CH3CN)2
(8.6 mg, 0.034 mmol) in HOAc (1.4 mL). The mixture was
stirred at room temperature for 24 h, and after the work-up,
flash column chromatography (silica gel, petroleum ether/
EtOAc 8/2) afforded 2e (63.9 mg, 55%, 79% conversion) as a
solid: mp (CH2Cl2): 126−128 °C; IR (ATR) 1718 cm−1 (C
O); 1H NMR (CDCl3, 300 MHz): δ 3.49 (s, 3H, OCH3), 3.81
(s, 6H, 2 × OCH3), 3.87 (s, 3H, OCH3), 6.02 (s, 1H, H3),
6.25 (d, J = 2.4 Hz, 1H, H6), 6.41 (d, J = 2.3 Hz, 2H, H2′, H6′),
6.49 (t, J = 2.3 Hz, 1H, H4′), 6.52 (d, J = 2.4 Hz, 1H, H8);
13C{1H} NMR (CDCl3, 75.5 MHz): δ 55.5 (2 × OCH3), 55.6
(OCH3), 55.8 (OCH3), 93.6 (C8), 95.9 (C6), 100.0 (C4′),
103.5 (C4a), 105.4 (C2′, C6′), 112.4 (C3), 141.7 (C1′), 155.5
(C4), 157.1 (C8a), 158.2 (C7), 160.0 (C3′, C5′), 160.9 (C5),
163.4 (CO); MS (ESI+) m/z (rel intensity) 344 (MH+ + 1,
16), 343 (MH+, 100); HRMS (ESI+) Calcd. for C19H19O6
[MH+]: 343.1182; found, 343.1180.
4-(Furan-3-yl)-5,7-dimethoxy-2H-chromen-2-one (2f).
Coumarin 2f was prepared from 1f (98.1 mg, 0.36 mmol),
1-fluoro-2,4,6-trimethylpyridinium trifluoromethanesulfonate
(124.1 mg, 0.43 mmol), Cu(OAc)2 (3.2 mg, 0.018 mmol),
p-TsOH (68.0 mg, 0.36 mmol), and PdCl2(CH3CN)2 (4.6 mg,
0.018 mmol) in HOAc (1.4 mL). The mixture was stirred at
room temperature for 24 h, and after the work-up, flash
column chromatography (silica gel, petroleum ether/EtOAc 8/
2) afforded 2f (20.6 mg, 21%, 75% conversion) as a solid: mp
(CH2Cl2): 153−155 °C; IR (ATR) 1714 cm−1 (CO); 1H
NMR (CDCl3, 300 MHz): δ 3.67 (s, 3H, OCH3), 3.89 (s, 3H,
OCH3), 6.09 (s, 1H, H3), 6.30 (d, J = 2.4 Hz, 1H, H6), 6.49−
6.52 (m, 2H, H8, H4′), 7.45 (t, J = 1.8 Hz, 1H, H5′), 7.56−7.57
(m, 1H, H2′);
13C{1H} NMR (CDCl3, 75.5 MHz): δ 55.3
(OCH3), 55.8 (OCH3), 93.6 (C8), 95.7 (C6), 103.4 (C4a),
112.1 (C4′), 112.5 (C3), 125.0 (C3′), 140.3 (C2′), 142.0 (C5′),
146.7 (C4), 157.3, 158.2, 160.8 (C8a, C5, C7), 163.3 (CO); MS
(ESI+) m/z (rel intensity) 274 (MH+ + 1, 12), 273 (MH+,




(2g). Coumarin 2g was prepared from 1g (87.5 mg, 0.27
mmol), 1-fluoro-2,4,6-trimethylpyridinium trifluoromethane-
sulfonate (94.9 mg, 0.33 mmol), Cu(OAc)2 (3.0 mg, 0.016
mmol), p-TsOH (79.3 mg, 0.27 mmol), and PdCl2(CH3CN)2
(8.5 mg, 0.032 mmol) in mesitylene (1.1 mL). The mixture
was stirred at 70 °C for 24 h, and after the work-up, flash
column chromatography (silica gel, hexane/EtOAc 8/2)
afforded 2g (25.8 mg, 30%) as a solid: mp (CH2Cl2): 170−
172 °C; IR (ATR) 1724 cm−1 (CO); 1H NMR (CDCl3, 300
MHz): δ 3.48 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 5.97 (s,
1H, H3), 6.23 (d, J = 2.4 Hz, 1H, H6), 6.51 (d, J = 2.4 Hz, 1H,
H8), 6.72−6.91 (m, 3H, H2′, H4′, H6′); 13C{1H} NMR
(CDCl3, 75.5 MHz): δ 55.6 (OCH3), 55.8 (OCH3), 93.7 (C8),
95.8 (C6), 102.8 (C4a), 103.2 (t, J = 25.2 Hz, C4′), 110.9−
112.7 (m, C2′, C6′), 112.7 (C3), 142.8 (t, J = 10.1 Hz, C1′),
153.0 (C4), 157.1 (C8a), 157.9 (C5), 160.3 (C7), 162.2 (dd, J =
248.1, 13.2 Hz, C3′, C5′), 163.8 (CO); MS (EI) m/z (rel
intensity) 319.1 (M+ + 1, 19), 318.1 (M+, 100), 291.1 (16),
290.1 (93), 275.1 (39), 247 (12), 188 (14), 175 (15), 69 (10);
HRMS (CI) Calcd. for C17H13 F2O4 [MH
+]: 319.0776; found,
319.0770.
5,7-Dimethoxy-2H-chromen-2-one (2h). Coumarin 2h was
prepared from 1h (94.4 mg, 0.45 mmol), 1-fluoro-2,4,6-
trimethylpyridinium trifluoromethanesulfonate (157.4 mg,
0.54 mmol), Cu(OAc)2 (4.1 mg, 0.023 mmol), p-TsOH
(131.6 mg, 0.45 mmol), and PdCl2(CH3CN)2 (5.9 mg, 0.023
mmol) in mesitylene (1.8 mL). The mixture was stirred at 70
°C for 4 h, and after the work-up, flash column
chromatography (silica gel, hexane/EtOAc 7/3) afforded 2h
(64.9 mg, 69%) as a white solid, whose data are coincidental
with those reported:46 mp (CH2Cl2): 144−146 °C [lit.46 mp
(CH2Cl2/pentanes) 143−145 °C]; IR (ATR) 1724 cm−1
(CO); 1H NMR (CDCl3, 300 MHz): δ 3.82 (s, 3H,
OCH3), 3.89 (s, 3H, OCH3), 6.15 (d, J = 9.7 Hz, 1H, H3),
6.28 (d, J = 2.1 Hz, 1H, H6), 6.41 (d, J = 2.1 Hz, 1H, H8), 7.96
(d, J = 9.7 Hz, 1H, H4);
13C{1H} NMR (CDCl3, 75.5 MHz): δ
55.8 (OCH3), 55.9 (OCH3), 92.8 (C8), 94.8 (C6), 104.0
(C4a), 110.9 (C3), 138.7 (C4), 156.8 (C8a), 157.0, 163.7 (C5,
C7), 161.5 (CO); MS (EI) m/z (rel intensity) 207 (M
+ + 1,
12), 206 (M+, 100), 178 (79), 163 (48), 135 (22); HRMS
(CI) Calcd. for C11H11O4 [MH
+]: 207.0652; found, 207.0658.
5,7-Dimethoxy-4-methyl-2H-chromen-2-one (2i). Cou-
marin 2i was prepared from 1i (84.2 mg, 0.38 mmol), 1-
fluoro-2,4,6-trimethylpyridinium trifluoromethanesulfonate
(131.5 mg, 0.45 mmol), Cu(OAc)2 (3.4 mg, 0.018 mmol),
p-TsOH (72.1 mg, 0.38 mmol), and PdCl2(CH3CN)2 (9.8 mg,
0.036 mmol) in mesitylene (1.5 mL). The mixture was stirred
at 70 °C for 24 h, and after the work-up, flash column
chromatography (silica gel, hexane/EtOAc 7/3) afforded 2i
(50.3 mg, 60%) as a white solid, whose data are coincidental
with those reported:46 mp (CH2Cl2): 166−168 °C [lit.46 mp
(methanol): 168−170 °C; IR (ATR) 1740 cm−1 (CO); 1H
NMR (CDCl3, 300 MHz): δ 2.50 (d, J = 1.2 Hz, 3H, CH3),
3.82 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 5.91 (br s, 1H, H3),
6.26 (d, J = 2.4 Hz, 1H, H6), 6.39 (d, J = 2.4 Hz, 1H, H8);
13C{1H} NMR (CDCl3, 75.5 MHz): δ 24.2 (CH3), 55.6
(OCH3), 55.7 (OCH3), 93.4 (C8), 95.4 (C6), 104.8 (C4a),
111.3 (C3), 154.5 (C8a), 156.9 (C4), 159.1, 162.8 (C5, C7),
161.0 (CO); MS (EI) m/z (rel intensity) 221 (M+ + 1, 13),
220 (M+, 100), 193 (11), 192 (91), 178 (10), 177 (73), 149




2j was prepared from 1j (61.0 mg, 0.26 mmol), 1-fluoro-2,4,6-
trimethylpyridinium trifluoromethanesulfonate (94.3 mg, 0.31
mmol), Cu(OAc)2 (2.4 mg, 0.013 mmol), p-TsOH (49.9 mg,
0.26 mmol), and PdCl2(CH3CN)2 (6.8 mg, 0.026 mmol) in
mesitylene (1 mL). The mixture was stirred at 70 °C for 24 h,
and after the work-up, flash column chromatography (silica gel,
hexane/EtOAc 7/3) afforded 2j (29.8 mg, 49%) as a solid,
whose data are coincidental with those reported:71 mp
(CH2Cl2): 141−143 °C [lit.71 mp (EtOH:H2O) 146−148
°C]; IR (ATR) 1710 cm−1 (CO); 1H NMR (CDCl3, 300
MHz): δ 1.21 (t, J = 7.3 Hz, 3H, CH3), 2.94 (q, J = 7.3 Hz,
2H, CH2), 3.84 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 6.00 (s,
1H, H3), 6.30 (d, J = 2.4 Hz, 1H, H6), 6.45 (d, J = 2.4 Hz, 1H,
H8);
13C{1H} NMR (CDCl3, 75.5 MHz): δ 13.5 (CH3), 29.4
(CH2), 55.7 (OCH3), 55.8 (OCH3), 93.6 (C8), 95.6 (C6),
104.3 (C4a), 109.7 (C3), 157.2 (C8a), 158.8 (C4), 159.9, 162.6
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(C5, C7), 161.4 (CO); MS (EI) m/z (rel intensity) 235 (M
+ +
1, 15), 234 (M+, 100), 207 (12), 206 (86), 205 (16), 191 (52),




marin 2k was prepared from 1k (77.0 mg, 0.31 mmol), 1-
fluoro-2,4,6-trimethylpyridinium trifluoromethanesulfonate
(112.4 mg, 0.37 mmol), Cu(OAc)2 (2.9 mg, 0.015 mmol),
p-TsOH (59.4 mg, 0.31 mmol), and PdCl2(CH3CN)2 (8.0 mg,
0.030 mmol) in mesitylene (1.2 mL). The mixture was stirred
at 70 °C for 24 h, and after the work-up, flash column
chromatography (silica gel, hexane/EtOAc 7/3) afforded 2k
(37.9 mg, 50%) as a solid, whose data are coincidental with
those reported:72 mp (CH2Cl2): 109−111 °C [lit.72 mp
(CHCl3) 113.5−115 °C]; IR (ATR) 1713 cm−1 (CO); 1H
NMR (CDCl3, 300 MHz): δ 1.00 (t, J = 7.3 Hz, 3H, CH2−
CH2−CH3), 1.52−1.69 (m, 2H, CH2−CH2−CH3), 2.82−2.88
(m, 2H, CH2−CH2−CH3), 3.84 (s, 3H, OCH3), 3.86 (s, 3H,
OCH3), 5.96 (s, 1H, H3), 6.30 (d, J = 2.4 Hz, 1H, H6), 6.45 (d,
J = 2.4 Hz, 1H, H8);
13C{1H} NMR (CDCl3, 75.5 MHz): δ
14.0 (CH2−CH2−CH3), 22.8 (CH2−CH2−CH3), 38.5
(CH2−CH2−CH3), 55.7 (OCH3), 55.8 (OCH3), 93.6 (C8),
95.6 (C6), 104.3 (C4a), 110.7 (C3), 157.3 (C8a), 158.2 (C4),
158.7, 162.6 (C5, C7), 161.3 (CO); MS (EI) m/z (rel
intensity) 249.1 (M+ + 1, 15), 248.1 (M+, 100), 233.1 (36),
220.1 (63), 205.1 (41), 192.1 (56), 191.1 (28), 178 (15),
177.1 (25), 161.1 (22), 146 (15), 91 (10), 77.1 (12), 69 (14);




marin 2p was prepared from 1p (60 mg, 0.21 mmol), 1-
fluoro-2,4,6-trimethylpyridinium trifluoromethanesulfonate
(75.9 mg, 0.25 mmol), Cu(OAc)2 (2.2 mg, 0.010 mmol), p-
TsOH (40.2 mg, 0.21 mmol), and PdCl2(CH3CN)2 (5.6 mg,
0.021 mmol) in mesitylene (1.0 mL). The mixture was stirred
at 70 °C for 24 h, and after the work-up, flash column
chromatography (silica gel, hexane/EtOAc 7/3) afforded 2p
(17.8 mg, 30%) as an oil, whose data are coincidental with
those reported:73 IR (ATR): 1715 cm−1 (CO); 1H NMR
(CDCl3, 300 MHz): δ 3.77 (s, 3H, OCH3), 3.99 (s, 3H,
OCH3), 6.26 (s, 1H, H3), 6.88 (s, 1H, H8), 6.94 (s, 1H, H5),
7.46−7.56 (m, 5H, Ph); 13C{1H} NMR (CDCl3, 75.5 MHz): δ
56.3 (OCH3), 56.4 (OCH3), 100.3 (C8), 107.5 (C5), 111.4
(C4a), 112.4 (C3), 128.3, 128.9, 129.7 (C2′, C3′, C4′, C5′, C6′),
135.8 (C1′), 146.1 (C4), 150.2 (C8a), 152.9, 155.6 (C6, C7),
161.4 (CO); MS (EI) m/z (rel intensity): 282 (M+, 100), 254
(23), 239 (16), 207 (27), 168 (10), 155 (12), 139 (15), 127




marin 2q was prepared from 1q (60.1 mg, 0.27 mmol), 1-
fluoro-2,4,6-trimethylpyridinium trifluoromethanesulfonate
(98.9 mg, 0.33 mmol), Cu(OAc)2 (5.1 mg, 0.027 mmol), p-
TsOH (52.2 mg, 0.27 mmol), and PdCl2(CH3CN)2 (7.1 mg,
0.027 mmol) in mesitylene (1.3 mL). The mixture was stirred
at 70 °C for 24 h, and after the work-up, flash column
chromatography (silica gel, hexane/EtOAc 7/3) afforded 2q
(20.3 mg, 34%) as a solid, whose data are coincidental with
those reported:71 mp (CH2Cl2): 128−129 °C [lit.71 mp
(EtOH:H2O) 128−129 °C]; IR (ATR): 1715 cm−1 (CO);
1H NMR (CDCl3, 300 MHz): δ 2.41 (d, J = 1.0 Hz, 3H, CH3),
3.94 (s, 6H, 2 × OCH3), 6.17 (d, J = 1.0 Hz, 1H, H3), 6.85 (s,
1H, H5), 6.94 (s, 1H, H8);
13C{1H} NMR (CDCl3, 75.5
MHz): δ 18.9 (CH3), 56.3 (OCH3), 56.4 (OCH3), 100.1 (C8),
105.2 (C5), 112.4 (C4a), 112.5 (C3), 146.2 (C4), 149.2 (C8a),
152.3, 159.1 (C6, C7), 161.5 (CO); MS (EI) m/z (rel
intensity): 220 (M+, 100), 192 (10), 149 (14), 1201 (10);




marin 2r was prepared from 1r (674 mg, 0.24 mmol), 1-fluoro-
2,4,6-trimethylpyridinium trifluoromethanesulfonate (88.3 mg,
0.31 mmol), Cu(OAc)2 (4.4 mg, 0.024 mmol), p-TsOH (48.8
mg, 0.24 mmol), and PdCl2(CH3CN)2 (6.2 mg, 0.024 mmol)
in mesitylene (1.0 mL). The mixture was stirred at 70 °C for
72 h, and after the work-up, flash column chromatography
(silica gel, petroleum ether/EtOAc 8/2) afforded 2r (13.0 mg,
18%) as an oil, whose data are coincidental with those
reported:74 IR (ATR): 1735 cm−1 (CO); 1H NMR (CDCl3,
300 MHz): δ 2.56 (d, J = 1.1 Hz, 3H, CH3), 3.85 (s, 3H,
OCH3), 3.91 (s, 3H, OCH3), 3.96 (s, 3H, OCH3), 6.04 (d, J =
1.1 Hz, 1H, H3), 6.64 (s, 1H, H8);
13C{1H} NMR (CDCl3,
75.5 MHz): δ 23.0 (CH3), 56.2 (OCH3), 61.0 (OCH3), 61.3
(OCH3), 96.2 (C8), 108.1 (C4a), 113.0 (C3), 139.2 (C6), 151.3
(C8a), 151.6 (C4), 153.6, 156.3 (C5, C7), 160.1 (CO); MS (EI)
m/z (rel intensity): 250 (M+, 90), 235 (100), 207 (75), 163
(39), 149 (14), 69 (17), 53 (14), 51 (13); HRMS (ESI+)
Calcd. for C13H15O5 [MH
+]: 251.0914; found, 251.0939.
4-Methyl-6,7-methylenedioxy-2H-chromen-6-one (2s).
Coumarin 2s was prepared from 1s (61.5 mg, 0.30 mmol),
1-fluoro-2,4,6-trimethylpyridinium trifluoromethanesulfonate
(101.1 mg, 0.35 mmol), Cu(OAc)2 (5.1 mg, 0.015 mmol),
p-TsOH (57.7 mg, 0.30 mmol), and PdCl2(CH3CN)2 (8.0 mg,
0.027 mmol) in mesitylene (1.5 mL). The mixture was stirred
at 70 °C for 96 h, and after the work-up, flash column
chromatography (silica gel, petroleum ether/EtOAc 7/3)
afforded 2s (13.0 mg, 20%) as a solid, whose data are
coincidental with those reported:75 mp (CH2Cl2): 120−122
°C; IR (ATR): 1735 cm−1 (CO); 1H NMR (CDCl3, 300
MHz): δ 2.37 (s, 3H, CH3), 6.07 (s, 2H, OCH2O), 6.17 (s,
1H, H3), 6.83 (s, 1H, H5), 6.96 (s, 1H, H8);
13C{1H} NMR
(CDCl3, 75.5 MHz): δ 19.1 (CH3), 98.4 (OCH2O), 102.1
(C8), 102.3 (C5), 112.2 (C4a), 113.8 (C3), 144.9 (C4), 150.6
(C8a), 150.9, 152.4 (C6, C7), 161.2 (CO); MS (EI) m/z (rel
intensity): 204 (M+, 100), 176 (72), 96 (15); HRMS (ESI+)
Calcd. for C11H9O4 [MH
+]: 205.0495; found, 205.0523.
(Z)-3-(3,5-Difluorobenzylidene)-4,6-dimethoxybenzofur-
an-2(3H)-ne (3g). Compound 3g was obtained from 1g (123.8
mg, 0.39 mmol), 1-fluoro-2,4,6-trimethylpyridinium trifluor-
omethanesulfonate (135.5 mg, 0.46 mmol), Cu(OAc)2 (3.6
mg, 0.019 mmol), p-TsOH (74.6 mg, 0.39 mmol), and
PdCl2(CH3CN)2 (5.1 mg, 0.019 mmol) in HOAc (1.5 mL).
The mixture was stirred at 70 °C for 24 h, and after the work-
up, flash column chromatography (silica gel, hexane/EtOAc 8/
2) afforded 2g (9.8 mg, 8%) and 3g (18.3 mg, 15%) as a solid:
mp (CH2Cl2): 202−204 °C; IR (ATR): 1774 cm−1 (CO);
1H NMR (CDCl3, 300 MHz): δ 3.85 (s, 3H, OCH3), 3.97 (s,
3H, OCH3), 6.26 (d, J = 2.0 Hz, 1H, H5), 6.32 (d, J = 2.0 Hz,
1H, H7), 6.79−6.88 (m, 1H, H4′), 7.49−7.63 (m, 1H, H2′,
H6′), 7.80 (s, 1H, CCH−Ar); 13C{1H} NMR (CDCl3, 75.5
MHz): δ 55.8 (OCH3), 55.9 (OCH3), 89.3 (C7), 94.3 (C5),
104.7−105.8 (m, C3a, C4′), 113.5−113.9 (m, C2′, C6′), 122.6
(C3), 136.4 (CCH−Ar), 136.9 (t, J = 10.0 Hz, C1′), 155.1
(C7a), 157.0 (C4), 162.6 (dd, J = 247.5, 13.0 Hz, C3′, C5′),
163.1 (C6), 165.8 (CO); MS (EI) m/z (rel intensity) 319 (M
+
+ 1, 19), 318 (M+, 100), 275 (28), 188 (12), 175 (11), 69
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(10); HRMS (ESI+) Calcd. for C17H13F2O4 [MH
+]: 319.0776;
found, 319.0783.
C3 Intermolecular C−H Alkenylation of Coumarins 2:
General Procedure. Over a solution of coumarins 2 (1
mmol) in 1,4-dioxane (5 mL), AgOAc (3 mmol), PivOH (10
mmol), and Pd(OAc)2 (0.1 or 0.2 mmol) were added. The
mixture was stirred vigorously for 5 min, and then the
corresponding acrylate (2 or 4 mmol) was added. The reaction
was heated at 120 °C for 24−48 h, and then the reaction was
allowed to cool down to room temperature. The mixture was
filtered through diatomaceus earth and the filtrate was
concentrated in vacuo. Flash column chromatography (silica
gel, hexane/EtOAc) afforded coumarins 4.
Methyl (E)-3-(5,7-Dimethoxy-2-oxo-4-phenyl-2H-chro-
men-3-yl)acrylate (4a). Coumarin 4a was prepared from 2a
(83.2 mg, 0.29 mmol), AgOAc (0.15 g, 0.88 mmol), PivOH
(0.30 g, 2.95 mmol), methylacrylate (0.06 mL, 0.59 mmol),
and Pd(OAc)2 (6.6 mg, 0.029 mmol). The reaction was heated
at 120 °C for 24 h, and after this, additional amounts of methyl
acrylate (0.06 mL, 0.59 mmol) and Pd(OAc)2 (6.6 mg, 0.029
mmol) were added, and it was heated again at 120 °C for 24 h.
After the work-up, flash column chromatography (silica gel,
hexane/EtOAc 7/3) afforded 4a (33.4 mg, 31%) as a solid: mp
(CH2Cl2) 194−196 °C; IR (ATR): 1710 cm−1 (CO); 1H
NMR (CDCl3, 300 MHz): δ 3.29 (s, 3H, CHCH−
COOCH3), 3.65 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 6.15
(d, J = 2,4 Hz, 1H, H6), 6.49 (d, J = 2,4 Hz, 1H, H8), 7.06−
7.15 (m, 4H, H2′, H4′, H6′, CHCH−COOCH3), 7.34−7.47
(m, 3H, H3′, H5′, CHCH−COOCH3); 13C{1H} NMR
(CDCl3, 75.5 MHz): δ 51.4 (CHCH−COOCH3), 55.7
(OCH3), 55.9 (OCH3), 93.1 (C8), 96.0 (C6), 104.7 (C4a),
115.7 (C3), 121.9 (CHCH−COOCH3), 127.1 (C2′, C6′),
127.8 (C3′, C5′), 127.9 (C4′), 137.2 (CHCH−COOCH3),
137.7 (C1′), 155.8 (C4), 156.0 (C8a), 159.1, 164.4 (C5, C7)
159.2 (CO), 168.4 (COOCH3); MS (CI) m/z (rel intensity)
368 (MH+ + 1, 19), 367 (MH+, 100), 336 (7), 335 (41);




men-3-yl)acrylate (4b). Coumarin 4b was prepared from 2a
(82.4 mg, 0.29 mmol), AgOAc (0.15 g, 0.88 mmol), PivOH
(0.30 g, 2.92 mmol), tert-butyl acrylate (85 μL, 0.58 mmol),
and Pd(OAc)2 (6.6 mg, 0.029 mmol). The reaction was heated
at 120 °C for 24 h, and after the work-up, flash column
chromatography (silica gel, CH2Cl2) afforded 4b (37.3 mg,
31%, 44% conversion) as a solid: mp (CH2Cl2) 148−150 °C;
IR (ATR): 1732 (COO), 1706 (COOtBu) cm−1; 1H NMR
(CDCl3, 300 MHz): δ 1.41 (s, 9H, C(CH3)3), 3.31 (s, 3H,
OCH3), 3.89 (OCH3), 6.17 (d, J = 2.4 Hz, 1H, H6), 6.52 (d, J
= 2.4 Hz, 1H, H8), 7.02−7.15 (m, 4H, H2′, H4′, H6′, CH
CH−COOtBu), 7.35−7.47 (m, 3H, H3′, H5′, CHCH−
COOtBu); 13C{1H} NMR (CDCl3, 75.5 MHz): δ 28.1
(C(CH3)3), 55.7 (OCH3), 55.9 (OCH3), 79.9 (C(CH3)3),
93.1 (C8), 96.0 (C6), 104.8 (C4a), 115.9 (C3), 124.4 (CH
CH−COOtBu), 127.1 (C3′, C5′), 127.7 (C4′), 127.9 (C2′, C6′),
135.9 (CHCH−COOtBu), 137.8 (C1′), 155.4, 155.9 (C4,
C8a), 159.1, 159.2 (C5, C7), 164.2 (CO), 166.9 (COOtBu);
MS (ESI+) m/z (rel intensity) 410 (MH+ + 1, 9), 409 (MH+,
45), 354 (16), 353 (100); HRMS (ESI+) Calcd. for C25H25O6
[MH+]: 409.1651; found, 409.1653.
Methyl (E)-3-{4-[4-(tert-Butyl)phenyl]-5,7-dimethoxy-2-
oxo-2H-chromen-3-ylacrylate (4c). Coumarin 4c was pre-
pared from 2d (85.0 mg, 0.25 mmol), AgOAc (0.13 g, 0.75
mmol), PivOH (0.26 g, 2.51 mmol), methyl acrylate (45 μL,
0.50 mmol), and Pd(OAc)2 (5.6 mg, 0.025 mmol). The
reaction was heated at 120 °C for 24 h, and after this,
additional amounts of methyl acrylate (45 μL, 0.50 mmol) and
Pd(OAc)2 (5.6 mg, 0.025 mmol) were added, and it was
heated again at 120 °C for 24 h. After the work-up, flash
column chromatography (silica gel, petroleum ether/EtOAc 8/
2) afforded 4c (55.4 mg, 52%, 63% conversion) as a solid: mp
(CH2Cl2): 159−162 °C; IR (ATR): 1726 cm−1 (CO); 1H
NMR (CDCl3, 300 MHz): δ 1.40 (s, 9H, C(CH3)3), 3.28 (s,
3H, COOCH3), 3.67 (s, 3H, OCH3), 3.88 (s, 3H, OCH3),
6.16 (d, J = 2.4 Hz, 1H, H6), 6.50 (d, J = 2.4 Hz, 1H, H8),
7.04−7.06 (m, 2H, H3′, H5′), 7.16 (d, J = 15.8 Hz, 1H, CH
CH−COOCH3), 7.24 (d, J = 15.8 Hz, 1H, CHCH−
COOCH3), 7.44−7.47 (m, 2H, H2′, H6′); 13C{1H} NMR
(CDCl3, 75.5 MHz): δ 31.3 (C(CH3)3), 34.7 (C(CH3)3), 51.4
(COOCH3), 55.8 (OCH3), 55.8 (OCH3), 93.1 (C8), 96.1
(C6), 105.0 (C4a), 115.7 (C3), 121.8 (CHCH−COOCH3),
124.7 (C3′, C5′), 126.9 (C2′, C6′), 134.6 (C1′), 137.4 (CH
CH−COOCH3), 150.8 (C4′), 156.0 (C4, C8a), 156.3, 159.2
(C5, C7), 164.3 (CO), 168.3 (COOCH3); MS (ESI
+) m/z (rel
intensity) 424 (MH+ + 1, 24), 423 (MH+, 100), 391 (20), 318




oxo-2H-chromen-3-yl]acrylate (4d). Coumarin 4d was
prepared from 2e (69.2 mg, 0.20 mmol), AgOAc (0.10 g,
0.61 mmol), PivOH (0.21 g, 2.02 mmol), methyl acrylate (36
μL, 0.40 mmol), and Pd(OAc)2 (4.5 mg, 0.020 mmol). The
reaction was heated at 120 °C for 24 h, and after this,
additional amounts of methyl acrylate (36 μL, 0.40 mmol) and
Pd(OAc)2 (4.5 mg, 0.020 mmol) were added, and it was
heated again at 120 °C for 24 h. After the work-up, flash
column chromatography (silica gel, petroleum ether/EtOAc 6/
4) afforded 4d (24.2 mg, 28%, 57% conversion) as a solid: mp
(CH2Cl2) 207−209 °C; IR (ATR): 1722 cm−1 (CO); 1H
NMR (CDCl3, 300 MHz): δ 3.40 (s, 3H, COOCH3), 3.69 (s,
3H, OCH3), 3.81 (s, 6H, 2 × OCH3), 3.88 (s, 3H, OCH3),
6.19 (d, J = 2.4 Hz, 1H, H6), 6.28−6.29 (m, 2H, H2′, H6′),
6.49−6.51 (m, 2H, H8, H4′), 7.15−7.27 (m, 2H, CHCH−
COOCH3);
13C{1H} NMR (CDCl3, 75.5 MHz): δ 51.5
(COOCH3), 55.5 (2 × OCH3), 55.9 (OCH3), 56.0 (OCH3),
93.1 (C8), 96.1 (C6), 99.8 (C4′), 104.6 (C4a), 105.5 (C2′, C6′),
115.5 (C3), 122.0 (CHCH−COOCH3), 137.2 (CHCH−
COOCH3), 139.5 (C1′), 155.5 (C4), 156.0 (C8a), 159.2, 160.6
(C5, C7), 164.4 (CO), 168.2 (COOCH3); MS (ESI
+) m/z (rel
intensity) 428 (MH+ + 1, 19), 427 (MH+, 100), 396 (10), 395




men-3-yl)acrylate (4e). Coumarin 4e was prepared from 2i
(81.3 mg, 0.37 mmol), AgOAc (0.19 g, 1.11 mmol), PivOH
(0.38 g, 3.69 mmol), methyl acrylate (0.07 mL, 0.74 mmol),
and Pd(OAc)2 (8.5 mg, 0.04 mmol). The reaction was heated
at 120 °C for 48 h, and after the work-up, flash column
chromatography (silica gel, hexane/EtOAc 6/4) afforded 4e
(50.7 mg, 45%) as a solid: mp (CH2Cl2) 199−201 °C; IR
(ATR): 1713 cm−1 (COO, COOCH3);
1H NMR (CDCl3, 300
MHz): δ 2.72 (s, 3H, CH3), 3.79 (s, 3H, COOCH3), 3.85 (s,
3H, OCH3), 3.88 (s, 3H, OCH3), 6.30 (d, J = 2,4 Hz, 1H, H6),
6.40 (d, J = 2,4 Hz, 1H, H8), 7.07 (d, J = 15,7 Hz, 1H, CH
CH−COOCH3), 7.82 (d, J = 15,7 Hz, 1H, CHCH−
COOCH3);
13C{1H} NMR (CDCl3, 75.5 MHz): δ 19.7
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(CH3), 51.7 (CHCH−COOCH3), 55.8 (OCH3), 55.9
(OCH3), 93.1 (C8), 96.0 (C6), 106.5 (C4a), 115.5 (C3),
123.1 (CHCH−COOCH3), 136.3 (CHCH−COOCH3),
154.5 (C4), 155.8 (C8a), 159.0, 163.5 (C5, C7), 159.8 (CO),
168.4 (COOCH3); MS (CI) m/z (rel intensity) 306 (MH
+ +
1, 14), 305 (MH+, 100), 274 (10), 273 (85); HRMS (CI)
Calcd. for C16H17O6 [MH
+]: 305.1020; found, 305.1021.
tert-Butyl (E)-3-(5,7-Dimethoxy-4-methyl-2-oxo-2H-chro-
men-3-yl)acrylate (4f). Coumarin 4f was prepared from 2i (60
mg, 0.27 mmol), AgOAc (0.14 g, 0.82 mmol), PivOH (0.28 g,
2.72 mmol), tert-butyl acrylate (0.08 mL, 0.54 mmol), and
Pd(OAc)2 (6.2 mg, 0.03 mmol). The reaction was heated at
120 °C for 24 h, and after the work-up, flash column
chromatography (silica gel, hexane/EtOAc 7/3) afforded 4f
(49.8 mg, 53%) as a solid: mp (CH2Cl2): 159−161 °C; IR
(ATR): 1716 (COO), 1695 (COOtBu) cm−1; 1H NMR
(CDCl3, 300 MHz): δ 1.51 (s, 9H, C(CH3)3), 2.69 (s, 3H,
CH3), 3.83 (s, 3H, OCH3), 3.87 (s, 3H, OCH3), 6.28 (d, J =
2.4 Hz, 1H, H6), 6.38 (d, J = 2.4 Hz, 1H, H8), 6.97 (d, J = 15.7
Hz, 1H, CHCH−COOtBu), 7.71 (d, J = 15.7 Hz, 1H,
CHCH−COOtBu); 13C{1H} NMR (CDCl3, 75.5 MHz): δ
19.6 (CH3), 28.2 (C(CH3)3), 55.7 (OCH3), 55.9 (OCH3),
80.3 (C(CH3)3), 93.1 (C8), 95.9 (C6), 105.5 (C4a), 115.6
(C3), 125.4 (CHCH−COOtBu), 135.0 (CHCH−COOt-
Bu), 154.0 (C8a), 155.7 (C4), 159.1, 159.7 (C5, C7), 163.4
(COO), 167.3 (COOtBu); MS (CI) m/z (rel intensity) 347.1
(MH+, 6), 346.1 (20), 292.1 (10), 291 (52), 290.1 (100),
274.1 (10), 273.1 (63), 262.1 (12), 245.1 (72); HRMS (CI)
Calcd. for C19H23O6 [MH
+]: 347.1489; found, 347.1507.
Methyl (E)-3-(5,7-Dimethoxy-4-methyl-2-oxo-2H-chro-
men-3-yl)but-2-enoate (4g). Coumarin 4g was prepared
from 2i (52.1 mg, 0.24 mmol), AgOAc (0.12 g, 0.71 mmol),
PivOH (0.24 g, 2.37 mmol), methyl crotonate (0.05 mL, 0.47
mmol), and Pd(OAc)2 (5.4 mg, 0.024 mmol). The reaction
was heated at 120 °C for 48 h. After the work-up, flash column
chromatography (silica gel, hexane/EtOAc 7/3) afforded 4g
(33.5 mg, 44%) as a solid: mp (CH2Cl2): 153−155 °C; IR
(ATR): 1706 cm−1 (COO, COOCH3);
1H NMR (CDCl3, 300
MHz): δ 2.39 (d, J = 1.3 Hz, 3H, C(CH3)CH(COOCH3)),
2.48 (s, 3H, C−CH3), 3.73 (s, 3H, C(CH3)CH-
(COOCH3)), 3.85 (s, 3H, OCH3), 3.86 (s, 3H, OCH3),
5.76−5.79 (m, 1H, C(CH3)CH(COOCH3)), 6.31 (d, J =
2,4 Hz, 1H, H6), 6.43 (d, J = 2,4 Hz, 1H, H8);
13C{1H} NMR
(CDCl3, 75.5 MHz): δ 19.4 (C(CH3)CH(COOCH3)),
20.7 (C−CH3), 51.1 (C(CH3)CH(COOCH3)), 55.7
(OCH3), 55.8 (OCH3), 93.2 (C8), 95.8 (C6), 104.8 (C4a),
111.4 (C3), 121.6 (C(CH3)CH(COOCH3)), 148.8 (C-
(CH3)CH(COOCH3)), 152.6 (C4), 155.8 (C8a), 159.4,
159.5 (C5, C7), 162.6 (CO), 166.5 (C(CH3)CH-
(COOCH3)); MS (ESI
+) m/z (rel intensity) 319 (MH+,
100), 288 (17), 287 (71); HRMS (ESI+) Calcd. for C17H19O6
[MH+]: 319.1176, found, 319.1171.
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